|
Volumn 49, Issue 12, 2015, Pages 1227-
|
Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEXAMPHETAMINE;
FLUOXETINE;
KETAMINE;
LAMOTRIGINE;
LITHIUM SALT;
LORAZEPAM;
QUETIAPINE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
LITHIUM DERIVATIVE;
NEUROLEPTIC AGENT;
TRANQUILIZER;
ADULT;
BIPOLAR DISORDER;
CASE REPORT;
DEPRESSION;
DISEASE SEVERITY;
DRUG EFFICACY;
ELECTROCONVULSIVE THERAPY;
HUMAN;
LETTER;
MANIA;
MIDDLE AGED;
PRESCRIPTION;
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION;
TRANSCRANIAL MAGNETIC STIMULATION;
TREATMENT DURATION;
TREATMENT RESPONSE;
COMBINATION DRUG THERAPY;
DEPRESSIVE DISORDER, TREATMENT-RESISTANT;
DRUG INTERACTION;
ANTIDEPRESSIVE AGENTS;
ANTIMANIC AGENTS;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
BIPOLAR DISORDER;
DEPRESSIVE DISORDER, TREATMENT-RESISTANT;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FLUOXETINE;
HUMANS;
KETAMINE;
LITHIUM COMPOUNDS;
LORAZEPAM;
MIDDLE AGED;
QUETIAPINE FUMARATE;
|
EID: 84949776037
PISSN: 00048674
EISSN: 14401614
Source Type: Journal
DOI: 10.1177/0004867415590631 Document Type: Letter |
Times cited : (21)
|
References (3)
|